Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease

Area of Science:

• Immunology
• Transplantation immunology

Background:

• Graft-versus-host disease (GVHD) is a major complication following allogeneic stem cell transplantation.
• Previous studies indicated that Interleukin-21 receptor (IL-21R) deficient splenocytes lead to less severe GVHD.

Purpose of the Study:

• To elucidate the mechanisms by which IL-21R signaling influences GVHD.
• To investigate the role of CD4(+) T cells lacking IL-21R in GVHD pathogenesis.

Main Methods:

• Transplantation of IL-21R gene-deficient donor CD4(+) T cells into recipient mice.
• Assessment of GVHD symptoms, including inflammatory cell infiltration and survival.
• Evaluation of T cell proliferation (MLR) and cytokine production in vitro.
• Analysis of regulatory T cell populations (CD25 depletion).

Main Results:

• Recipients of IL-21R deficient CD4(+) T cells showed reduced GVHD symptoms and prolonged survival.
• Diminished inflammatory cell infiltration was observed in the liver and intestine.
• Impaired mixed lymphocyte reaction (MLR) and reduced cytokine production by CD4(+) T cells were noted.
• CD25 depletion did not affect the ameliorated GVHD, suggesting regulatory T cells are not the primary mechanism.

Conclusions:

• IL-21 signaling promotes GVHD potentially through enhanced effector CD4(+) T cell differentiation.
• The attenuated GVHD observed is likely due to impaired effector T cell differentiation, not increased regulatory T cell activity.